Details:

Alternative Title:
Am J Prev Med
Publisher's site:
http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/http://dx.doi.org/10.1177/0886260520945676
Personal Author:
Jacob, Verughese ; Reynolds, Jeffrey A. ; Chattopadhyay, Sajal K. ; Hopkins, David P. ; Therrien, Nicole L. ; ... More +
Jacob, Verughese ; Reynolds, Jeffrey A. ; Chattopadhyay, Sajal K. ; Hopkins, David P. ; Therrien, Nicole L. ; Jones, Christopher D. ; Durthaler, Jeffrey M. ; Rask, Kimberly J. ; Cuellar, Alison E. ; Clymer, John M. ; Kottke, Thomas E. Less -
Corporate Authors:
Community Preventive Services Task Force (CPSTF)
Description:
Introduction:

Adherence to medications for cardiovascular disease (CVD) and its risk factors is less than optimal though greater adherence to medication has been shown to reduce the risk factors for CVD. This paper examines the economics of tailored pharmacy interventions to improve medication adherence for CVD prevention and management.

Methods:

Literature from inception of databases to May 2019 was searched, yielding 29 studies for CVD prevention and 9 studies for CVD management. Analyses were done from June 2019 through May 2020. All monetary values are in 2019 U.S. dollars.

Results:

The median intervention cost per patient per year was $246 for CVD prevention and $292 for CVD management. The median change in healthcare cost per person per year because of the intervention was −$355 for CVD prevention and −$2,430 for CVD management. The median total cost per person per year was −$89 for CVD prevention, with a median return on investment of 0.01. The median total cost per person per year for CVD management was −$1,080, with a median return on investment of 7.52 and 6 of 7 estimates indicating reduced healthcare cost averted exceeded intervention cost. For CVD prevention, the median cost per quality-adjusted life year gained was $11,298. There were no cost-effectiveness studies for CVD management.

Discussion:

The evidence shows tailored pharmacy-based interventions to improve medication adherence are cost effective for CVD prevention. For CVD management, healthcare cost averted exceeds the cost of implementation for a favorable return on investment from a healthcare systems perspective.


Subject:
[+]
Article
Child
Female
Gender Identity
Gender Role
Humans
Male
Nigeria
Sex Offenses
Sexual Behavior

Source:
Am J Prev Med. 62(3):e202-e222
Pubmed ID:
34876318
Pubmed Central ID:
PMC8863641
Document Type:
Journal Article
Funding:
CC999999/ImCDC/Intramural CDC HHSUnited States/
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:f98cf21c63e1362592614162c1212fb191c3bdff9a760ed87c03bca0dbc69d1b
File Type:

Supporting Files

• 	nihms-1768637-f0001.gif	gif
  	nihms-1768637-f0001.jpg	jpeg
  	nihms-1768637.nxml	xml
  	NIHMS1768637-supplement-1.pdf	pdf

More +